Showing results (341-350 of 388) with videos related to

Sort By:
Pageof 39
Neuro-Oncology|April 17, 2021
Meclofenamate causes loss of cellular tethering and decoupling of functional networks in glioblastomaMatthias Schneider, Lea Vollmer, Anna-Laura Potthoff, et al.
Brain Pathology (Zurich, Switzerland)|October 23, 2024
CIC/ATXN1-rearranged tumors in the central nervous system are mainly represented by sarcomas: A comprehensive clinicopathological and epigenetic seriesArnault Tauziède-Espariat, Azadeh Ebrahimi, Nathalie Boddaert, et al.
Neuro-Oncology|October 11, 2017
Multicenter pilot study of radiochemotherapy as first-line treatment for adults with medulloblastoma (NOA-07)Dagmar Beier, Martin Proescholdt, Christiane Reinert, et al.
Nature Communications|April 8, 2026
L-RNA aptamer-based CXCL12 inhibition combined with radiotherapy and bevacizumab in newly-diagnosed glioblastoma: expansion of the phase I/II GLORIA trialFrank A Giordano, Julian P Layer, Roberta Turiello, et al.
The Lancet. Oncology|December 5, 2019
EANO-EURACAN clinical practice guideline for diagnosis, treatment, and follow-up of post-pubertal and adult patients with medulloblastomaEnrico Franceschi, Silvia Hofer, Alba A Brandes, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 14, 2022
A Sequential Targeting Strategy Interrupts AKT-Driven Subclone-Mediated Progression in GlioblastomaSied Kebir, Vivien Ullrich, Pia Berger, et al.
Brain Pathology (Zurich, Switzerland)|April 21, 2020
cIMPACT-NOW update 6: new entity and diagnostic principle recommendations of the cIMPACT-Utrecht meeting on future CNS tumor classification and gradingDavid N Louis, Pieter Wesseling, Kenneth Aldape, et al.
Acta Neuropathologica Communications|November 19, 2024
Diffuse pediatric high-grade glioma of methylation-based RTK2A and RTK2B subclasses present distinct radiological and histomolecular features including Gliomatosis cerebri phenotypeArnault Tauziède-Espariat, Lea L Friker, Gunther Nussbaumer, et al.
Acta Neuropathologica|May 17, 2018
Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic featuresMaximilian Y Deng, Martin Sill, Jason Chiang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Bevacizumab Plus Irinotecan Versus Temozolomide in Newly Diagnosed O6-Methylguanine-DNA Methyltransferase Nonmethylated Glioblastoma: The Randomized GLARIUS TrialUlrich Herrlinger, Niklas Schäfer, Joachim P Steinbach, et al.
Pageof 39